Pharmacological Care of Hypertension Due to Glucocorticoid Drugs

doi:10.19803/j.1672-8629.20240283

Abstract

Abstract: Objective To investigate the priorities of pharmacological care of patients with hypertension due to glucocorticoid drugs and the effectiveness of pharmacists’ intervention. Methods Clinical pharmacists explored the key to such care, clinical management measures and effectiveness of pharmacological care of two patients who developed pharmacogenetic hypertension after using glucocorticoid medications. Results and conclusion Clinical pharmacists can effectively assist clinicians in the rational use of clinical medications to ensure safety by providing effective pharmacological care for patients with pharmacogenetic hypertension.

Key words: Clinical Pharmacist, Pharmacological Care, Glucocorticoid, Pharmacogenic Hypertension, Clinical Management, Rational Use of Clinical Medication

CLC Number:

LIU Xin, WANG Guojun. Pharmacological Care of Hypertension Due to Glucocorticoid Drugs[J]. Chinese Journal of Pharmacovigilance, 2024, 21(11): 1303-1305.

Add to citation manager EndNote|Ris|BibTeX

URL: https://zgywjj.magtechjournal.com/EN/10.19803/j.1672-8629.20240283

https://zgywjj.magtechjournal.com/EN/Y2024/V21/I11/1303

References

[1] CAI BQ, YAN XX, et al.Expert Consensus on Acute Exacerbation of Chronic Obstructive Pulmonary Disease in the People’s Republic of China(2023 Revised Edition)[J]. Int J Respir, 2023, 43(2): 132-149.
[2] ELLIOTT WJ.Drug interactions and Drugs that Affect Blood Pressure[J]. J Clin Hypertens (Greenwich), 2006, 8(10): 731-737.
[3] SARATHY H, SALMAN LA, LEE C, et al.Evaluation and Management of Secondary Hypertension[J]. Med Clin North Am, 2022, 106(2): 269-283.
[4] SUNDERRAM J, ANDROULAKIS IP.Molecular Mechanisms of Chronic Intermittent Hypoxia and Hypertension[J]. Crit Rev Biomed Eng, 2012, 40(4): 265-278.
[5] NESTEROV V, BERTOG M, CANONICA J, et al.Critical Role of the Mineralocorticoid Receptor in Aldosterone-dependent and Aldosterone-independent Regulation of ENaC in the Distal Nephron[J]. Am J Physiol Renal Physiol, 2021, 321(3): F257-F268.
[6] GOODWIN JE, GELLER DS.Glucocorticoid-induced Hypertension[J]. Pediatr Nephrol, 2012, 27(7): 1059-1066.
[7] PRZYBYCIŃSKI J, DROŻDŻAL S, DOMAŃSKI L, et al. Role of Endothelial Glucocorticoid Receptor in the Pathogenesis of Kidney Diseases[J]. Int J Mol Sci, 2021, 22(24): 13295.
[8] VEROUTI S, HUMMLER E, VANDERRIELE PE.Role of Glucocorticoid Receptor Mutations in Hypertension and Adrenal Gland hyperplasia[J]. Pflugers Arch, 2022, 474(8): 829-840.
[9] POFI R, CARATTI G, RAY DW, et al.Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good from the Bad?[J]. Endocr Rev, 2023, 44(6): 975-1011.
[10] CHEN ZY, GE JB, HUANG K, et al.Consensus of Chinese Experts on Standardized Diagnosis and Treatment Under the Joint Management of“three highs”(2023)[J]. Chinese Video Journal of Cardiology(中华心血管病杂志), 2023, 6(1): 1-11.
[11] KUPCZYK D, BILSKI R, KOZAKIEWICZ M, et al.11β-HSD as a New target in Pharmacotherapy of Metabolic Diseases[J]. Int J Mol Sci, 2022, 23(16): 8984.

[1]	ZHANG Caixia, ZHOU Yi, TAN Lu, CHEN Wenming, LIU Yang, YOU Yu. Pharmaceutical care of pulmonary aspergillus infection secondary to sepsis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(9): 1064-1067.
[2]	ZHANG Qian, YUN Yuan, HE Lian. Pharmaceutical care of hyperprolactinemia in a patient induced by risperidone [J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 936-938.
[3]	LIN Yanxin, LIU Yanhui, DONG Jing, YAO Jiachen, LI Wenyan. Pharmaceutical care of acute liver injury in a patient with colon cancer induced by irinotecan [J]. Chinese Journal of Pharmacovigilance, 2024, 21(6): 693-696.
[4]	LI haiyan, YANG Zhongxu, LIU Yuekun, WANG Lihong. Pharmaceutical care of serious adverse reactions due to methotrexate treatment of ectopic pregnancy [J]. Chinese Journal of Pharmacovigilance, 2024, 21(4): 454-456.
[5]	LIU Qi, ZHANG Yufeng, LUO Hao, LI Xin. Analysis of the rationality and safety of clinical application of anrotinib in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(3): 329-334.
[6]	FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184.
[7]	CHEN Jie, QIN Kan. Evaluation of individualized parenteral nutrition delivery [J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 812-816.
[8]	LIU Jing, XIA Liang, ZHANG Shijie. Pharmaceutical care of a patient with acute pancreatitis complicated with multiple drug allergy undergoing drug stimulation test [J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 822-824.
[9]	JIA Zhaoguang, XU Wenshuai, JI Li’na, WANG Linlin, ZHAO Li’na, ZHAO Jingquan, MU Xiangdong. Diagnosis and treatment of mycoplasma pneumoniae pneumonia in children and rational administration of related drugs [J]. Chinese Journal of Pharmacovigilance, 2023, 20(12): 1391-1395.
[10]	SU Su, WU Shiqi, ZHANG Qingxia, YAN Suying. Pharmaceutical care of a patient with indapamide-induced agranulocytosis [J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1282-1285.
[11]	WEI Hongtao, SHEN Su, LI Dandan, LIAO Yin. Pareto chart analysis of 705 problematic prescriptions in neurology [J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 900-903.
[12]	YUAN Xiaolong, WAN Qihua, TAO Donghong, QI Hao, WANG Aixia. Pharmaceutical care of a severely poisoned patient with methotrexate tablets [J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 924-928.
[13]	SUN Xuelin, ZHANG Pan, HU Xin. Pharmaceutical care of a case of severe ulcerative colitis treated with vedolizumab [J]. Chinese Journal of Pharmacovigilance, 2022, 19(7): 782-785.
[14]	TANG Jingya. Pharmaceutical care by a clinical pharmacists in the treatment of parenteral nutrition related hepatic damage: a case report [J]. Chinese Journal of Pharmacovigilance, 2022, 19(7): 786-788.
[15]	YANG Baochun, SUN Xin, YANG Xin, WU Lin, WANG Liping. Pharmaceutical care for a patient with urinary tract infection and drug fever [J]. Chinese Journal of Pharmacovigilance, 2022, 19(5): 572-573.